Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
Despite the risk to humans remaining low, HHS has pledged $306 million to its response to the highly pathogenic avian influenza A(H5N1 ... for any possible scenario that could arise," Xavier Becerra, Secretary of the Department of Health and Human Services ...
January 5, 2025 - Last Friday, the U.S. Department of Health and Human Services (HHS) announced it would award $306 million dollars to continue its H5N1 Avian Flu response. While CDC’s assessment of the risk of avian influenza to the general public remains low,
The U.S. Department of Health and Human Services has put 306 million dollars into avian influenza monitoring and preparedness. Dr. Keith Poulsen with the Wisconsin Veterinary Diagnostic Laboratory tells Brownfield most of the funding announced Friday is not new money and is being used to bolster a possible future public health response.
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
Is it seasonal flu or bird flu? CDC prompts hospitals to fast-track subtype testing of sick patients to tell the difference.
The U.S. Department of Health and Human Services (HHS) announced it would award $306 million to continue its H5N1 avian influenza response.